I'm thinking either a director is buying or the Japan deal is close/done. Or, it could just be traders bringing it back to fair value.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025